(Reuters) - The U.S. Food and Drug Administration said on Wednesday that it had approved Pfizer Inc's drug, Xeljanz, to treat adults with moderate-to-severe active ulcerative colitis.
from Reuters: Health https://ift.tt/2JiiDxG
FDA clears Pfizer's Xeljanz for inflammatory bowel disease
Reviewed by RK Creations
on
May 31, 2018
Rating: 5
No comments